Category: biotech

.AstraZeneca has utilized artificial intelligence to devise an unique biomarker for its Daiichi Sankyo-partnered datopotamab deruxtecan (Dato-DXd), hoping to separate the antibody-drug conjugate (ADC) coming

.AN2 Rehabs is actually reviewing its company in reaction to uninspired midphase records, pledging to lay off half its staff members as well as stop

.ALX Oncology’s phase 2 gastric cancer cells response rate has actually diminished. After viewing its own CD47 blocker simply beat control over the 1st fifty

.After greater than two decades of work on neurodegenerative diseases, Swiss biotech a/c Invulnerable claims it could have a game changer on its hands.The company’s